An e-health interactive self-assessment website (Sanoia®) in rheumatoid arthritis. A 12-month randomized controlled trial in 320 patients - 15/11/18
, Alain Cantagrel c, Martin Soubrier d, Jean-Marie Berthelot e, Jean-Michel Joubert f, Bernard Combe g, Wienia Czarlewski f, Daniel Wendling h, Emmanuelle Dernis i, Laurent Grange j, Catherine Beauvais k, Aleth Perdriger l, Henri Nataf m, Maxime Dougados n, o, p, Hervé Servy qBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
| pagine | 6 |
| Iconografia | 2 |
| Video | 0 |
| Altro | 0 |
Highlights |
• | In this randomized controlled trial, giving access to the interactive Sanoia e-health platform led to a small improvement in patient-perceived patient-physician interactions. |
• | E-Health platforms are promising adjuncts to physician care in RA. |
• | Although mean satisfaction with the platform was very high, around a quarter of the patients did not use the interactive platform. |
• | Future studies of e-health should measure not only patient satisfaction but a combination of both patient satisfaction and utilization. |
Abstract |
Introduction |
Sanoia is an online interactive electronic e-health platform developed to allow patient self-assessment and self-monitoring. The objective was to assess in rheumatoid arthritis (RA) patients, the efficacy on patient-physician interactions, of giving access to Sanoia.
Methods |
In this French, multi-center, 12-months randomized controlled trial (CarNET: NCT02200068), patients with RA and internet access were randomized to: access without incentives to the Sanoia platform after minimal training, or usual care. The primary outcome was the change from baseline in patient-physician interactions, by the patient-reported Perceived Efficacy in Patient–Physician Interactions (PEPPI-5) questionnaire. The number of accesses to Sanoia was recorded and satisfaction with the platform was assessed through a 0–10 numeric rating scale. Analyses were in intention to treat (ITT), on SAS.
Results |
Of 320 RA patients (159 Sanoia versus 161 usual care), mean (standard deviation) age was 57.0 (12.7) years, mean (SD) disease duration was 14.6 (11.1) years, 216 (67.5%) were taking a biologic and 253 (79.1%) were female. Mean (SD) PEPPI scores at baseline and 12 months were 38.6 (8.2) and 39.2 (8.0) (delta=+0.60 [5.52]) versus 39.7 (7.3) and 38.8 (8.0) (delta=−0.91 [6.08]) in the Sanoia and control group, respectively (P=0.01). Although mean satisfaction with the platform was very high (1.46 [1.52]), 41 patients (25.7%) never accessed Sanoia.
Conclusion |
Giving RA patients access to the interactive Sanoia e-health platform led to a small improvement in patient-perceived patient-physician interactions. A disjunction between patient satisfaction and access to the platform was noted. E-Health platforms are promising in RA.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Rheumatoid arthritis, Disease activity, Patient attitude to health, E-health, Electronic health records, Patient-reported outcome measures, Quality of life, Quality of health care
Mappa
Vol 85 - N° 6
P. 709-714 - dicembre 2018 Ritorno al numero
Articolo precedente
- Epigenetics of bone diseases
- Laetitia Michou
- Resilience in women with autoimmune rheumatic diseases
- Manuel Rojas, Yhojan Rodriguez, Yovana Pacheco, Elizabeth Zapata, Diana M. Monsalve, Rubén D. Mantilla, Monica Rodríguez-Jimenez, Carolina Ramírez-Santana, Nicolás Molano-González, Juan-Manuel Anaya
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?